Published On: Wed, Oct 19th, 2016

Current Price Targets For Invacare Corporation (NYSE:IVC)

Recently stock market analysts have updated their consensus ratings on shares of Invacare Corporation (NYSE:IVC).

Most recent broker ratings

10/24/2014 – Invacare Corporation was upgraded to “buy” by analysts at KeyBanc. They now have a USD 17 price target on the stock.

10/24/2013 – Invacare Corporation was downgraded to “neutral” by analysts at Sidoti.

10/08/2013 – Invacare Corporation was upgraded to “neutral” by analysts at Zacks. They now have a USD 17 price target on the stock.

Invacare Corporation has a 50 day moving average of 11.42 and a 200 day moving average of 11.84. The stock’s market capitalization is 336.05M, it has a 52-week low of 9.89 and a 52-week high of 20.41.

The share price of the company (NYSE:IVC) was up +0.98% during the last trading session, with a high of 10.50 and the volume of Invacare Corporation shares traded was 189520.

Invacare Corporation is a manufacturer and distributor for medical equipment used in non-acute care settings. The Company’s geographical segments are Europe; North America, which includes North America/Home Medical Equipment (North America/HME) and Institutional Products Group (IPG) segments, and Asia/Pacific. The Company manufactures and distributes three product categories: mobility and seating, lifestyle and respiratory therapy. It provides medical device solutions for congenital (cerebral palsy, muscular dystrophy and spina bifida), acquired (stroke, spinal cord injury, traumatic brain injury, post-acute recovery and pressure ulcers) and degenerative (amyotrophic lateral sclerosis, multiple sclerosis, chronic obstructive pulmonary disease (COPD), elderly and bariatric) ailments. The Company sells its products to home medical equipment providers with retail and e-commerce channels, residential living operators, distributors and government health services.